Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah

Toxicon

Volumn 60, Issue 3, 2012, Pages 290-301

  Zeng, Lin ^a,c   Sun, Qian Yun ^b   Jin, Yang ^a   Zhang, Yong ^a   Lee, Wen Hui ^a   Zhang, Yun ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cobra venom factor; Complement depleting activity; Molecular cloning; Ophiophagus hannah; Purification

Indexed keywords

COBROTOXIN; COMPLEMENTARY DNA; CYSTEINE;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DNA FINGERPRINTING; DNA SEQUENCE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; MOLECULAR PHYLOGENY; MOLECULAR WEIGHT; NAJA; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; OPHIOPHAGUS HANNAH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TOXIN ANALYSIS; TOXIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHINA; COBRA; COBRA VENOMS; COMPLEMENT INACTIVATING AGENTS; CYSTEINE; ERYTHROCYTES; HUMANS; LECTINS, C-TYPE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; OXIDATION-REDUCTION; PHYLOGENY; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; REPTILIAN PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP, DOMESTIC;

AUSTRELAPS SUPERBUS; NAJA ATRA; NAJA HAJE; NAJA KAOUTHIA; NAJA MELANOLEUCA; NAJA NAJA NAJA; NAJA SIAMENSIS; OPHIOPHAGUS HANNAH;

EID: 84861884569     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.04.344     Document Type: Article

References (53)

1. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 2004, 340:783-795.
2. Birdsey V., Lindorfer J., Gewurz H. Interaction of toxic venoms with the complement system. Immunology 1971, 21:299-310.
3. Chang C.C., Huang T.Y., Kuo K.W., Chen S.W., Huang K.F., Chiou S.H. Sequence characterization of a novel alpha-neurotoxin from the king cobra (Ophiophagus hannah) venom. Biochem. Biophys. Res. Commun. 1993, 191:214-223.
4. Daha M.R. Role of complement in innate immunity and infections. Crit. Rev. Immunol. 2010, 30:47-52.
5. de Bruijn M.H., Fey G.H. Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:708-712.
6. Eggertsen G., Lind P., Sjoquist J. Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja N. siamensis). Mol. Immunol. 1981, 18:125-133.
7. Fritzinger D.C., Bredehorst R., Vogel C.W. Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12775-12779.
8. Fritzinger D.C., Dean R., Meschter C., Wong K., Halter R., Borlak J., St John W.D., Vogel C.W. Complement depletion with humanized cobra venom factor in a mouse model of age-related macular degeneration. Adv. Exp. Med. Biol. 2010, 703:151-162.
9. Fritzinger D.C., Ferreira V.P., Hew B.E., St. John W., Pangburn M.K., Vogel C.-W. A novel concept for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): complement depletion with a human C3 derivative withcobra venomfactor-like activityprevents lysisof PNH erythrocytes. Abstracts/Mol. Immunol. 2008, 8:244.
10. Fritzinger D.C., Hew B.E., Lee J.Q., Newhouse J., Alam M., Ciallella J.R., Bowers M., Gorsuch W.B., Guikema B.J., Stahl G.L., Vogel C.W. Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agents. Adv. Exp. Med. Biol. 2008, 632:293-307.
11. Fritzinger D.C., Petrella E.C., Connelly M.B., Bredehorst R., Vogel C.W. Primary structure of cobra complement component C3. J. Immunol. 1992, 149:3554-3562.
12. Gorsuch W.B., Guikema B.J., Fritzinger D.C., Vogel C.W., Stahl G.L. Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury. Mol. Immunol. 2009, 47:506-510.
13. Gowda D.C., Glushka J., Halbeek H., Thotakura R.N., Bredehorst R., Vogel C.W. N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures. Glycobiology 2001, 11:195-208.
14. Gowda D.C., Petrella E.C., Raj T.T., Bredehorst R., Vogel C.W. Immunoreactivity and function of oligosaccharides in cobra venom factor. J. Immunol. 1994, 152:2977-2986.
15. Guo X.X., Zeng L., Lee W.H., Zhang Y., Jin Y. Isolation and cloning of a metalloproteinase from king cobra snake venom. Toxicon 2007, 49:954-965.
16. He Y.Y., Lee W.H., Zhang Y. Cloning and purification of alpha-neurotoxins from king cobra (Ophiophagus hannah). Toxicon 2004, 44:295-303.
17. Hensley P., O'Keefe M.C., Spangler C.J., Osborne J.C., Vogel C.W. The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor B. J. Biol. Chem. 1986, 261:11038-11044.
18. Jin Y., Lee W.H., Zeng L., Zhang Y. Molecular characterization of L-amino acid oxidase from king cobra venom. Toxicon 2007, 50:479-489.
19. Jones D.T., Taylor W.R., Thornton J.M. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 1992, 8:275-282.
20. Kock M.A., Hew B.E., Bammert H., Fritzinger D.C., Vogel C.W. Structure and function of recombinant cobra venom factor. J. Biol. Chem. 2004, 279:30836-30843.
21. Kolln J., Braren I., Bredehorst R., Spillner E. Purification of native and recombinant cobra venom factor using thiophilic adsorption chromatography. Protein Pept. Lett. 2007, 14:475-480.
22. Lachmann P.J., Halbwachs L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin. Exp. Immunol. 1975, 21:109-114.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
24. Lee W.H., Zhang Y. Molecular cloning and characterization of a platelet glycoprotein Ib-binding protein from the venom of Trimeresurus stejnegeri. Toxicon 2003, 41:885-892.
25. Li Z.Y., Yu T.F., Lian E.C. Purification and characterization of L-amino acid oxidase from king cobra (Ophiophagus hannah) venom and its effects on human platelet aggregation. Toxicon 1994, 32:1349-1358.
26. Lundwall A., Wetsel R.A., Domdey H., Tack B.F., Fey G.H. Structure of murine complement component C3. I. Nucleotide sequence of cloned complementary and genomic DNA coding for the beta chain. J. Biol. Chem. 1984, 259:13851-13856.
27. Misumi Y., Sohda M., Ikehara Y. Nucleotide and deduced amino acid sequence of rat complement C3. Nucleic Acids Res. 1990, 18:2178.
28. Muller-Eberhard H.J., Fjellstrom K.E. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J. Immunol. 1971, 107:1666-1672.
29. Nagaki K., Iida K., Okubo M., Inai S. Reaction mechanisms of beta1H globulin. Int. Arch. Allergy Appl. Immunol. 1978, 57:221-232.
30. Osipov A.V., Mordvintsev D.Y., Starkov V.G., Galebskaya L.V., Ryumina E.V., Bel'tyukov P.P., Kozlov L.V., Romanov S.V., Doljansky Y., Tsetlin V.I., Utkin Y.N. Naja melanoleuca cobra venom contains two forms of complement-depleting factor (CVF). Toxicon 2005, 46:394-403.
31. Pangburn M.K., Muller-Eberhard H.J. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem. J. 1986, 235:723-730.
32. Pung Y.F., Wong P.T., Kumar P.P., Hodgson W.C., Kini R.M. Ohanin, a novel protein from king cobra venom, induces hypolocomotion and hyperalgesia in mice. J. Biol. Chem. 2005, 280:13137-13147.
33. Rajagopalan N., Pung Y.F., Zhu Y.Z., Wong P.T., Kumar P.P., Kini R.M. Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity. FASEB J. 2007, 21:3685-3695.
34. Rehana S., Manjunatha Kini R. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus. Toxicon 2007, 50:32-52.
35. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
36. Sharma S., Jabeen T., Singh R.K., Bredhorst R., Vogel C.W., Betzel C., Singh T.P. Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis. Acta Crystallogr. D Biol. Crystallogr. 2001, 57:596-598.
37. Sun Q.Y., Lu Q.M., Wang W.Y., Xiong Y.L. A highly active anticomplement factor from the venom of Naja kaouthia. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2001, 33:483-488.
38. Takahashi H., Hayashi K. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom. Biochim. Biophys. Acta 1982, 701:102-110.
39. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
40. Tan N.H., Saifuddin M.N. Isolation and characterization of an unusual form of L-amino acid oxidase from King cobra (Ophiophagus hannah) venom. Biochem. Int. 1989, 19:937-944.
41. Tan N.H., Saifuddin M.N. Purification and characterization of two acidic phospholipase A2 enzymes from king cobra (Ophiophagus hannah) snake venom. Int. J. Biochem. 1990, 22:481-487.
42. Tan N.H., Saifuddin M.N. Substrate specificity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase. Int. J. Biochem. 1991, 23:323-327.
43. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
44. Vogel C.W., Bredehorst R., Fritzinger D.C., Grunwald T., Ziegelmuller P., Kock M.A. Structure and function of cobra venom factor, the complement-activating protein in cobra venom. Adv. Exp. Med. Biol. 1996, 391:97-114.
45. Vogel C.W., Fritzinger D.C. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon 2010, 56:1198-1222.
46. Vogel C.W., Fritzinger D.C., Hew B.E., Thorne M., Bammert H. Recombinant cobra venom factor. Mol. Immunol. 2004, 41:191-199.
47. Vogel C.W., Muller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 1982, 257:8292-8299.
48. Vogel C.W., Muller-Eberhard H.J. Cobra venom factor: improved method for purification and biochemical characterization. J. Immunol. Methods 1984, 73:203-220.
49. Vogel C.W., Smith C.A., Muller-Eberhard H.J. Cobra venom factor: structural homology with the third component of human complement. J. Immunol. 1984, 133:3235-3241.
50. von Zabern I., Hinsch B., Przyklenk H., Schmidt G., Vogt W. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology 1980, 157:499-514.
51. von Zabern I., Przyklenk H., Vogt W. Chain structure of cobra venom factor from Naja naja and Naja haje venom. Scand. J. Immunol. 1982, 15:357-362.
52. Wetsel R.A., Lundwall A., Davidson F., Gibson T., Tack B.F., Fey G.H. Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the alpha chain. J. Biol. Chem. 1984, 259:13857-13862.
53. Zhang Y., Lee W.H., Xiong Y.L., Wang W.Y., Zu S.W. Characterization of OhS1, an arginine/lysine amidase from the venom of king cobra (Ophiophagus hannah). Toxicon 1994, 32:615-623.